Biology Direct

Table 1 The analysis between SFMBT2 expression and clinical information of clear cell RCC patients

From: Acetylation- and ubiquitination-regulated SFMBT2 acts as a tumor suppressor in clear cell renal cell carcinoma

Variable	Category	No. of cases		χ²	p value
		SFMBT2 Low	SFMBT2 High
		n = 29	n = 32
Age	≤ 60	17	20	0.01809	0.89300
Age	> 60	12	12	0.01809	0.89300
Gender	Male	15	16	0.09593	0.75676
Gender	Female	14	16	0.09593	0.75676
TNM stage	I–II	14	25	5.87833	0.01533*
TNM stage	III–IV	15	7	5.87833	0.01533*
T stage	T1–T2	14	26	7.32732	0.00679**
T stage	T3–T4	15	6	7.32732	0.00679**

Back to article page

ISSN: 1745-6150

Contact us

General enquiries: journalsubmissions@springernature.com